Telehealth Increase Underscores Need for MA Risk Adjustment

Just days after CMS mentioned in its final 2021 Medicare Advantage and Part D rate notice that it would issue separate guidance on the topic of telehealth and risk adjustment (see story, p. 1), the Trump administration unveiled a major shift in telehealth policy by giving plans new latitude to apply diagnoses from telehealth visits for risk adjustment purposes. While this removes a longstanding barrier to MA plans’ use of the technology, it remains unclear whether CMS is making a permanent policy change.

“The 2019 Coronavirus Disease (COVID-19) pandemic has resulted in an urgency to expand the use of virtual care to reduce the risk of spreading the virus,” said the agency in an April 10 memo to plans. “CMS is stating that Medicare Advantage (MA) organizations and other organizations that submit diagnoses for risk adjusted payment are able to submit diagnoses for risk adjustment that are from telehealth visits when those visits meet all criteria for risk adjustment eligibility, which include being from an allowable inpatient, outpatient, or professional service, and from a face-to-face encounter.”

© 2023 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

congressional-building
June 1

‘Devil Will Be in the Details’ of Forthcoming Medicare-Medicaid Duals Bill

READ MORE
bills-and-pills
June 1

Proposed Rule Targets PBMs’ Medicaid Practices, Creates Pharma Pricing Audit

READ MORE
unitedhealthcare
June 1

National Carriers Net 80% of 500,000 MA Sign-Ups During Open Enrollment Period

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today